Search
for
Sort by
Research 811–840 of 1000+
- Disorders in Male Sexual Differentiation Due to 5α-Reductase-2 Deficiency
- A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex
- Impact of a Novel Dehydroepiandrosterone Derivative on the Metabolism of RWPE-1 and LNCaP Cell Lines
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of
- Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models
- Androgenic alopecia and its association with metabolic syndrome
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Bioavailability File: Bicalutamide
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- MP11-05 THE UROLOGIC IMPACT OF LONG-TERM FINASTERIDE-1 MG USE FOR ANDROGENIC ALOPECIA: A MATCHED-COHORT DATABASE ANALYSIS
- Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- African Journal of Biomedical Research
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Сечова кислота в житті чоловіка
- MP09-17 METHYLATION OF SRD5A2 IN THE BLOOD AS A NOVEL BIOMARKER TO PREDICT SENSITIVITY TO 5-ARI TREATMENT
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Testosterone Hormone ; Clinical Indications, Dysregulation and Therapeutic methods
- Thiohydrazides in the Synthesis of Functionalized Extranuclear Heterosteroids
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- Potential Pharmacological Activities of Pumpkin Seeds as a Functional Food: A Comprehensive Review
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands
- Structural basis for the catalysis and inhibition of human steroid 5α‐reductase 2
- In vitro and In vivo Effects of 17β-N-(4-phenylcarbamoyl) androst-4-en-3- one Derivatives as 5a-reductase Inhibitors on Androgen-dependent Glands